Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1962 Feb;41(2):235–244. doi: 10.1172/JCI104475

THE THROMBOTIC ACTIVITY OF ACTIVATION PRODUCT*

Edward S Henderson 1,†, Samuel I Rapaport 1
PMCID: PMC289218  PMID: 13906393

Full text

PDF
236

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALEXANDER N., HINSHAW L. B., DRURY D. R. Mechanism of congestive heart failure following aorta constriction in rabbits. Circ Res. 1957 Jul;5(4):375–381. doi: 10.1161/01.res.5.4.375. [DOI] [PubMed] [Google Scholar]
  2. BERGSAGEL D. E., HOUGIE C. Intermediate stages in the formation of blood thromboplastin. Br J Haematol. 1956 Apr;2(2):113–129. doi: 10.1111/j.1365-2141.1956.tb06820.x. [DOI] [PubMed] [Google Scholar]
  3. BORCHGREVINK C. F., POOL J. G., STORMORKEN H. A new assay for factor V (proaccelerin-accelerin) using Russell's viper venom. J Lab Clin Med. 1960 Apr;55:625–632. [PubMed] [Google Scholar]
  4. DEYKIN D., WESSLER S., REIMER S. M. Evidence for an antithrombotic effect of Dicumarol. Am J Physiol. 1960 Dec;199:1161–1164. doi: 10.1152/ajplegacy.1960.199.6.1161. [DOI] [PubMed] [Google Scholar]
  5. HJORT P., RAPAPORT S. I., OWREN P. A. A simple, specific one-stage prothrombin assay using Russell's viper venom in cephalin suspension. J Lab Clin Med. 1955 Jul;46(1):89–97. [PubMed] [Google Scholar]
  6. LANGDELL R. D., WAGNER R. H., BRINKHOUS K. M. Effect of antihemophilic factor on one-stage clotting tests; a presumptive test for hemophilia and a simple one-stage antihemophilic factor assy procedure. J Lab Clin Med. 1953 Apr;41(4):637–647. [PubMed] [Google Scholar]
  7. LOELIGER E. A., van der ESCH, ter HAAR C., ROMENY WACHTER, BOOIJ H. L. Factor VII; its turnover rate and its possible role in thrombogenesis. Thromb Diath Haemorrh. 1960 Mar 1;4:196–200. [PubMed] [Google Scholar]
  8. OWREN P. A., AAS K. The control of dicumarol therapy and the quantitative determination of prothrombin and proconvertin. Scand J Clin Lab Invest. 1951;3(3):201–208. doi: 10.3109/00365515109060600. [DOI] [PubMed] [Google Scholar]
  9. RAPAPORT S. I., AAS K., OWREN P. A. The effect of glass upon the activity of the various plasma clotting factors. J Clin Invest. 1955 Jan;34(1):9–19. doi: 10.1172/JCI103067. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. RAPAPORT S. I., AAS K., OWREN P. A. The lipid inhibitor of brain; mechanism of its anticoagulant action and its comparison with the soybean inositol phosphatide inhibitor. J Lab Clin Med. 1954 Sep;44(3):364–373. [PubMed] [Google Scholar]
  11. RAPAPORT S. I., AMES S. B. Clotting factor assays on plasma from patients receiving intramuscular of subcutaneous heparin. Am J Med Sci. 1957 Dec;234(6):678–686. doi: 10.1097/00000441-195712000-00006. [DOI] [PubMed] [Google Scholar]
  12. RAPAPORT S. I. Evidence that glass increases plasma PTA activity. J Lab Clin Med. 1958 Oct;52(4):624–633. [PubMed] [Google Scholar]
  13. RAPAPORT S. I. Possible relationships between clotting factors in vitro and intravascular clotting. Angiology. 1959 Oct;10:391–395. doi: 10.1177/000331975901000510. [DOI] [PubMed] [Google Scholar]
  14. RAPAPORT S. I., SCHIFFMAN S., PATCH M. J., WARE A. G. A simple, specific one-stage assay for plasma thromboplastin antecedent activity. J Lab Clin Med. 1961 May;57:771–780. [PubMed] [Google Scholar]
  15. RATNOFF O. D., DAVIE E. W., MALLETT D. L. Studies on the action of Hageman factor: evidence that activated Hageman factor in turn activates plasma thromboplastin antecedent. J Clin Invest. 1961 May;40:803–819. doi: 10.1172/JCI104314. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. REIMER S. M., WESSLER S., DEYKIN D. Serum thrombotic accelerator (STA) activity: its relation to the first phase of clotting. Proc Soc Exp Biol Med. 1960 Nov;105:438–442. doi: 10.3181/00379727-105-26133. [DOI] [PubMed] [Google Scholar]
  17. SCHIFFMAN S., RAPAPORT S. I., WARE A. G., MEHL J. W. Separation of plasma thromboplastin antecedent (PTA) and Hageman factor (HF) from human plasma. Proc Soc Exp Biol Med. 1960 Dec;105:453–455. doi: 10.3181/00379727-105-26138. [DOI] [PubMed] [Google Scholar]
  18. SPAET T. H., CINTRON J. Clearance of blood coagulation product I in rabbits. Proc Soc Exp Biol Med. 1960 Jul;104:498–500. doi: 10.3181/00379727-104-25888. [DOI] [PubMed] [Google Scholar]
  19. STAPP W. F. A one stage method for the assay of antihemophilic factor B (AHF B) with a comment on the antihemophilic factor B (AHF B) concentration in phenylindanedione (PID) therapy. Scand J Clin Lab Invest. 1958;10(2):169–176. [PubMed] [Google Scholar]
  20. STORMORKEN H. The preparation of proaccelerin deficient (parahemophilia) plasma for the assay of proaccelerin. Scand J Clin Lab Invest. 1957;9(3):273–276. doi: 10.3109/00365515709079970. [DOI] [PubMed] [Google Scholar]
  21. WESSLER S., REIMER S. M., SHEPS M. C. Biologic assay of a thrombosis-inducing activity in human serum. J Appl Physiol. 1959 Nov;14:943–946. doi: 10.1152/jappl.1959.14.6.943. [DOI] [PubMed] [Google Scholar]
  22. WESSLER S., REIMER S. M. The role of human coagulation factors in serum-induced thrombosis. J Clin Invest. 1960 Feb;39:262–265. doi: 10.1172/JCI104036. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. WESSLER S., REINER L., FREIMAN D. G., REIMER S. M., LERTZMAN M. Serum-induced thrombosis. Studies of its induction, and evolution under controlled conditions in vivo. Circulation. 1959 Nov;20:864–874. doi: 10.1161/01.cir.20.5.864. [DOI] [PubMed] [Google Scholar]
  24. WESSLER S. Studies in intravascular coagulation. I. Coagulation changes in isolated venous segments. J Clin Invest. 1952 Nov;31(11):1011–1014. doi: 10.1172/JCI102685. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. WESSLER S. Studies in intravascular coagulation. III. The pathogenesis of serum-induced venous thrombosis. J Clin Invest. 1955 Apr;34(4):647–651. doi: 10.1172/JCI103114. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES